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Abstract The oxysterols, 7ß-hydroxycholesterol and 7-keto-
cholesterol, are involved in the cytotoxicity of oxidized LDL. To 
elucidate their molecular mechanisms, the human promonocytic 
leukemia cells U937 and U4 were used. U4 cells overexpressing 
Bcl-2 were obtained by transfection of U937 cells. 7ß-
hydroxycholesterol and 7-ketocholesterol induced nuclear con-
densation and/or fragmentation, internucleosomal DNA frag-
mentation, and IL-lß secretion, which were partially inhibited by 
Bcl-2 overexpression. These findings underline that these 
oxysterols could constitute major risk factors in atherosclerosis 
by their cytotoxicity and their ability to induce IL-lß release 
which might favor the recruitment of immunocompetent cells in 
the atherosclerotic plaque. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Oxysterols which result from enzymatic or non-enzymatic 
oxidation of cholesterol are presumed to mediate cytotoxicity 
of oxidized low density lipoproteins (LDL) towards different 
cell types [1,2]. The mode of cell death that they induce on 
endothelial cells [3,4], smooth muscle cells [5], and monocytic 
cells [6,7] present typical features of apoptosis which is a 
highly conserved process in various species and organs [8]. 
In contrast to necrosis [9], initiation of apoptosis is an active 
and gene-directed mode of cell death which requires de novo 
gene expression and new protein synthesis [10]. Some death-
regulating genes (ced= cell death abnormal) have been identi-
fied in the nematode Caenorhabditis elegans, and homologous 
nucleic acid sequences are present in humans [8]. These par-
ticular ced genes which regulate cell death encode either for 
proteins which promote or protect from cell death [11]. Some 
of these gene products are involved in apoptosis induced by 
oxysterols. Thus, apoptosis triggered by 7-ketocholesterol or 
25-hydroxycholesterol on vascular smooth muscle cells from 
rabbit aorta or on murine macrophage-like P388-D1 cells ac-
tivates the CPP32 protease [5,7] which is a cysteinyl aspartate-
specific proteinase (caspase) [12] homolog of ced-3 gene prod-
uct, and which belongs to the interleukin-lß-converting en-
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zyme (ICE) family [13]. CPP32 promotes apoptosis by cleav-
ing and inactivating the poly-(ADP ribose) polymerase 
(PARP) [14], and its activity can be inhibited with synthetic 
tetrapeptides such as Ac-DEVD-CHO which reduces apopto-
sis [5,7]. On the murine macrophage P388-D1 cells treated 
either with 7-ketocholesterol or with 25-hydroxycholesterol 
it was also reported that Bcl-2 (homolog of ced-9 gene prod-
uct which can protect from cell death in multiple contexts 
[15]) partially blocked apoptosis induced by oxysterols [7]. 
As 7ß-hydroxycholesterol and 7-ketocholesterol are the 
main cytotoxic oxysterols present in oxidized LDL [1,16], 
we demonstrated in the present work that they were potent 
inducers of apoptosis on the human promonocytic leukemia 
cells U937, and we attempted to elucidate their molecular 
mechanisms. To this end, U4 cells which overexpressed Bcl-
2 protein were established by transfection of U937 cells [17] to 
investigate the effect of Bcl-2 overexpression on 7ß-hydroxy-
cholesterol and 7-ketocholesterol induced apoptosis. Since the 
processing and the release of interleukin-lß can occur during 
the apoptotic process [18-20], we also asked wether 7ß-hy-
droxycholesterol and 7-ketocholesterol could stimulate IL-lß 
secretion, and whether this phenomenon could be modulated 
by Bcl-2 overexpression. 
2. Materials and methods 
2.1. Transfection and cell culture 
Infection of the human promonocytic leukemia cells U937 with the 
pSFFV vector, containing Bcl-2 gene and neo-resistant gene (U4 
cells), was performed by electroporation as previously described 
[17]. Transfected cells were selected for 14 days in the presence of 
400 |ig/ml of geneticin (Boehringer Mannheim, Meylan, France) and 
cloned by limited dilution. U937 cells were grown in suspension in 
culture medium consisting of RPMI 1640 medium (Gibco, Eragny, 
France), 2 mmol/1 L-glutamine (Gibco), and antibiotics (100 U/ml 
penicillin, 100 ag/ml streptomycin) (Gibco) supplemented with 10% 
(vol/vol) heat-inactivated fetal calf serum (Boehringer Mannheim). U4 
cells were grown in the previously cultured medium, and cultured 
every two weeks for one passage with 200 ug/ml of geneticin (Boehr-
inger Mannheim); the functionality of overexpressed Bcl-2 through 
passages was regularly assessed by increased cell survival in serum 
deprived medium. U937 and U4 cells were seeded at 2X105 per ml 
of culture medium, passaged twice a week and incubated at 37°C 
under a 5% C02/95% air atmosphere. 
2.2. Cell treatments 
7ß-hydroxycholesterol and 7-ketocholesterol solutions were pre-
pared as previously described [3,4,21], and they were introduced in 
the culture medium at the beginning of the culture. In all the experi-
ments, cells were treated with 7ß-hydroxycholesterol (Steraloids Inc., 
Wilton, USA) and 7-ketocholesterol (Steraloids Inc.) for 24 h. The 
purity of 7ß-hydroxycholesterol and of 7-ketocholesterol determined 
by CPG/SM was 99% and 100%, respectively. 
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2.3. Cell counting 
Cell counting was performed with a hematocytometer under an 
inverted phase contrast microscope Laborlux IX 70 (Olympus, Tokyo, 
Japan). 
2.4. Fluorescence microscopy 
Nuclear morphology of control and treated cells was studied by 
fluorescence microscopy after staining with Hoechst 33342 (Sigma); 
apoptotic cells were essentially characterized by nuclear condensation 
of chromatin and/or nuclear fragmentation [22]. Hoechst 33342 was 
prepared extemporaneously in distilled water at 1 mg/ml, and was 
added in the culture medium at a final concentration of 10 ug/ml. 
After 1 h of incubation at 37°C, cells were washed twice in PBS, 
and resuspended at a concentration of 106 cells/ml in PBS containing 
1% (w/v) paraformaldehyde. Cell deposits of about 40000 cells were 
applied to glass slides by cytocentrifugation for 5 min at 15000 rpm 
with a cytospin 2 (Shandon, Cheshire, UK), mounted in Fluoprep 
(Biomérieux, Marcy l'Etoile, France), coverslipped and stored in 
dark at 4°C. The morphological aspect of cell nuclei was observed 
with an inverted microscope Laborlux 1X70 (Olympus) by using an 
UV light excitation, and for each sample 300 cells were examined. 
2.5. Transmission electron microscopy 
For transmission electron microscopy 20X106 cells were fixed for 
1 h with 2% glutaraldehyde prepared in a 0.1 mol/1 cacodylate buffer 
(pH 7.4), postfixed in osmium tetroxide, dehydrated with graded etha-
nol series, and finally embedded in Epon. Sections were stained with 
uranyl acetate and lead citrate, and were examined with an electron 
microscope H 600 (Hitachi, Tokyo, Japan). 
cipitated by two volumes of 100% ethanol and left overnight at 
—20°C. After centrifugation, DNA was resuspended in 100 ul TE 
buffer (10 mmol/1 Tris-HCl, 0.2 mmol/1 Na2EDTA, pH 7.5) before 
quantitation by spectrofluorimetry. The size of DNA standards used 
to evaluate DNA fragmentation ranged from 100 to 2072 bp (Gibco). 
Electrophoresis was carried out for 15 h at 20 V in 1.8% agarose gel 
prepared in TBE buffer (80 mmol/1 Tris-Borate (pH 8.0), 2 mmol/1 
EDTA) and containing 0.1 Ug/ml ethidium bromide. After electropho-
resis, gels were examined under ultraviolet light, photographed or 
computerized with an images analysis system (Biocom, Les Ulis, 
France). 
2.9. Statistical methods 
Statistical analyses were performed with SYSTAT software (Evan-
ston, IL, USA), by using a two way analysis of variance followed by a 
Dunnett /-test to compare the effects of 7ß-hydroxycholesterol and of 
7-ketocholesterol on U937 and U4 cells. 
3. Results 
3.1. 7ß-Hydroxycholesterol and 7-ketocholesterol 
induced apoptosis 
As shown in Fig. 1A, B, after 24 h of treatment in the 
presence of 7ß-hydroxycholesterol or of 7-ketocholesterol 
used in a range of concentrations from 5 to 80 tig/ml, the 
number of U937 and of U 4 cells was decreased, and simulta-
neously the number of U937 and of U 4 apoptotic cells in-
2.6. Flow cytometry analysis of Bcl-2 expression 
Intracellular Bcl-2 expression was determined by flow cytometry on 
U937 and U4 cells as previously described [23]. Briefly, cells were 
washed twice in PBS, and fixed with PBS containing 4% paraformal-
dehyde for 15 min at 4°C. After washing in PBS, they were incubated 
for 2 h at 4°C with the anti bcl-2 monoclonal antibody (Dako, Co-
penhagen, Denmark) diluted 1/10 in PBS/0.5% BSA/0.1% saponine. 
The cells were subsequently washed in PBS/0.5% BSA/0.1% saponine, 
and incubated for 30 min at 4°C with fluorescein-conjugated F(ab')2 
fragments of rabbit immunoglobulins directed against mouse immu-
noglobulins (Dako) diluted 1/100 in PBS/0.5% BSA/0.1% saponine. 
Finally, the cells were washed in PBS/0.1% saponin, resuspended in 
PBS, and stored in dark at 4°C until flow cytometry analysis on a 
FACScan flow cytometer (Becton-Dickinson, Mountain View, CA, 
USA). Cells only stained with the fluorescent conjugate were used 
as control conjugate. For each assay 5000 cells were analysed. Green 
fluorescence signal of fluorescein was collected through a 530/30 nm 
band pass filter, and fluorescence intensity was measured on a loga-
rithmic scale of 4 decades of log. Data were analyzed with the soft-
ware LYSYS II (Becton-Dickinson). 
2.7. Analysis of interleukin-1 ß secretion by ELISA 
To determine interleukin-lß (IL-lß) secretion, control and treated 
U937 and U4 cells were used. Briefly, the cells were seeded at 2X 106 
cells per well of 6 well plates (Nunc, Roskilde, Denmark) containing 
3 ml of culture medium, and immediately after the beginning of the 
culture 7ß-hydroxycholesterol and 7-ketocholesterol were introduced 
in the culture medium at 5, 10, 20, 40 and 80 ug/ml. After 24 h of 
treatment, the culture medium of control and treated cells was col-
lected by centrifugation, and the cells present in the pellet were 
counted after resuspension in phosphate-buffered saline (PBS). IL-
lß concentration in the culture medium was measured according to 
the manufacturer's procedure with a high sensitivity ELISA Kit (R 
and D, Abingdon, UK) which permits to detect as few as 0.125 pg per 
ml of IL-lß. All measurements were performed at least in triplicate, 
and the data were expressed in pg of IL-lß per 106 cells. 
2.8. DNA fragmentation assays 
DNA fragmentation assays were performed by electrophoresis on 
1.8% agarose gel. To this end, cellular DNA was extracted as previ-
ously described [24] by using a DNA extraction kit (Stratagene, La 
Jolla, CA, USA). Briefly, after overnight cell lysis at 37°C in a lysis 
buffer containing 10 mmol/1 EDTA, 400 mmol/1 NaCl, 1 mg/ml pro-
teinase K, 35 mmol/1 SDS and 10 mmol/1 Tris-HCl (pH 8.2), each tube 
was centrifugated and the supernatant containing the DNA was pre-
7ß-hydroxy cholesterol 7-ketocholesterol 
concentrations ((Xg/ml) 
Fig. 1. Cell growth inhibition, induction of apoptotic cells, and of 
IL-lß secretion under treatment with 7ß-hydroxycholesterol or 7-ke-
tocholesterol. U937 cells and U4 cells (overexpressing Bcl-2) cul-
tured in 6 well plates were treated for 24 h with 7ß-hydroxycholes-
terol and 7-ketocholesterol used in a range of concentrations from 
5 to 80 ug/ml. At the end of the incubation period, the following 
parameters were measured: total numbers of cells per well (A-B), 
proportions of apoptotic cells (C-D), and IL-lß secretion (E-F). 
Data are means ± S.D. of four independent experiments. Significance 
of the difference between U937 and U4 cells: *P<0.05; **P<0.01. 
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Fig. 2. Morphological characterization of oxysterols treated cells. U937 cells were incubated for 24 h in culture medium with or without oxy-
sterols. Subsequently, U937 cells were observed by fluorescence microscopy after nuclei staining with Hoechst 33342, and by transmission elec-
tron microscopy. A and B (X 1000): Fluorescence microscopy of untreated U937 cells (A) and of U937 cells treated with 20 ug/ml of 7ß-hy-
droxycholesterol (B), condensed nuclei (en) and fragmented nuclei (fn) are observed. B and C (X7000): Transmission electron microscopy of 
untreated U937 cells (C) and of U937 cells treated with 40 ug/ml of 7-ketocholesterol (D), a fragmented nucleus with condensed chromatin (cc) 
is observed. 
creased (Fig. IC, D). Apoptotic cells were characterized by 
condensed and/or fragmented nuclei which were observed by 
fluorescence microscopy after nuclei staining with Hoechst 
33342, and by electron microscopy (Fig. 2). 
cholesterol or of 7-ketocholesterol, analogous internucleoso-
mal DNA fragmentation patterns were found on U937 and 
U4 cells (data not shown). 
3.2. Bcl-2 overexpression partially inhibits 7ß-hydroxy-
cholesterol and 7-ketocholesterol induced apoptosis 
To examine whether Bcl-2 overexpression protect against 
apoptosis induced by 7ß-hydroxycholesterol or 7-ketocholes-
terol, we compared the cytotoxic effects of these oxysterols on 
U937 and U4 cells at 5, 10, 20, 40 and 80 ug/ml. Bcl-2 over-
expression in U4 cells was demonstrated by flow cytometry 
(Fig. 3). Under treatment with 7ß-hydroxycholesterol or 7-
ketocholesterol, we observed a significant (P<0.01) higher 
number of U4 cells than of U937 cells, and a significant 
(P<0.01) lower proportion of apoptotic U4 cells than of 
apoptotic U937 cells only at 20 and 40 ug/ml (Fig. 1A D). 
Furthermore, the ability of Bcl-2 overexpression to protect 
from apoptosis was assessed by a comparative analysis of the 
DNA fragmentation pattern on agarose gel (Fig. 4). At 5 and 
10 ug/ml no DNA degradation was observed on both cell lines 
(data not shown). On U937 cells treated with 20 and 40 u,g/ml 
of 7ß-hydroxycholesterol or of 7-ketocholesterol an internu-
cleosomal DNA fragmentation typical of apoptosis was de-
tected. On U4 cells, the internucleosomal DNA degradation 
was suppressed when 7ß-hydroxycholesterol or 7-ketocholes-
terol was used at 20 |ig/ml. With 40 ug/ml of 7ß-hydroxy-
cholesterol or of 7-ketocholesterol similar internucleosomal 
DNA fragmentation patterns were revealed in U937 cells 
and in U4 cells. Similarly, with 80 ug/ml of 7ß-hydroxy-
Fig. 3. Flow cytometry analysis of Bcl-2 expression. Bcl-2 expression 
was quantified by flow cytometry on U937 cells (A), and on U4 
cells (B) transfected with the viral vector pSFW-neo-Bcl-2. Bcl-2 ex-
pression was measured with a FACScan flow cytometer on a loga-
rithmic scale of fluorescence. For each assay, 10000 cells were ana-
lyzed. Shaded histograms: Bcl-2 expression; unshaded histograms: 
conjugated control. 
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Fig. 4. Effect of Bcl-2 overexpression on the internucleosomal DNA 
fragmentation induced by 7ß-hydroxycholesterol and 7-ketocholes-
terol. Analysis of DNA fragmentation by electrophoresis on 1.8% 
agarose gel was performed on U937, and U4 cells (overexpressing 
Bcl-2) which were untreated (1), or treated with 20 Lig/ml (2) or 40 
Hg/ml (3) of 7ß-hydroxycholesterol (7ß) or of 7-ketocholesterol (7-
keto). 
3.3. 7ß-Hydroxycholesterol and 7-ketocholesterol induced 
IL-lß secretion: partial inhibition by Bcl-2 overexpression 
Untreated U937 and U4 cells spontaneously produced low 
levels of IL-lß, and IL-lß secretion was strongly stimulated 
both in U937 and U4 cells when 7ß-hydroxycholesterol or 7-
ketocholesterol was added in the culture medium (Fig. IE, F). 
Under treatment with 7ß-hydroxycholesterol, IL-lß secretion 
was increased in U937 and U4 cells at 20, 40 and 80 Lig/ml, 
and at these different concentrations IL-lß secretion was sig-
nificantly (P<0.01) lower in U4 than in U937 cells (Fig. IE). 
With 7-ketocholesterol, IL-lß secretion was increased in U937 
and U4 cells at 10, 20, 40 and 80 ug/ml, and IL-lß secretion 
was significantly lower in U4 than in U937 cells only at 10 Lig/ 
ml (P<0.01) and 20 Lig/ml (P<0.05) (Fig. IF). 
4. Discussion 
Increased plasma levels of LDL are considered as a risk 
factor for atherosclerosis [25], and oxidized LDL have been 
shown to induce cytotoxic effects on a variety of cell types 
[1,2]. Among the principal components of oxidized LDL re-
sponsible for cellular injury, oxysterols play a critical role 
both in vivo and in vitro [26,27], particularly those oxidized 
in C7 such as 7ß-hydroxycholesterol and 7-ketocholesterol 
[3,21,28]. In the present work, which was performed on 
U937 and U4 cells (overexpressing Bcl-2 and obtained by 
transfection of U937 cells with the pSFFV-neo-BcI-2 vector 
[17]), we showed that 7ß-hydroxycholesterol and 7-keto-
cholesterol induced apoptosis both on U937 and U4 cells, 
and that this mode of cell death was associated with IL-lß 
secretion. The most relevant protective effect of overexpressed 
Bcl-2 characterized both by a lower proportion of apoptotic 
cells, by a total inhibition of internucleosomal DNA fragmen-
tation, and by a significant reduction of IL-lß secretion was 
observed only with 20 Lig/ml of 7ß-hydroxycholesterol and of 
7-ketocholesterol. Therefore, in the range of oxysterol concen-
trations used (5 to 80 Lig/ml), apoptosis as well as IL-lß se-
cretion were partially prevented by Bcl-2 overexpression. 
As reported in previous studies, cell death induced by oxy-
sterols share many common features of apoptotic cell death 
[3,5-7], and the present work demonstrates that 7ß-hydroxy-
cholesterol and 7-ketocholesterol are potent inducers of apop-
tosis, not only on U937 cells but also on U4 cells whereas 
these later ones overexpressed a functional Bcl-2 protein 
which protected them from apoptosis when they were used 
as targets in cytotoxicity assays [17]. Since Bcl-2 overexpres-
sion partially inhibits apoptosis induced either by 7-keto-
cholesterol and 25-hydroxycholesterol in the murine macro-
phage P388-D1 cells [7] or by 7ß-hydroxycholesterol and 7-
ketocholesterol on U4 cells (present work), these data strongly 
suggest that Bcl-2 overexpression is not sufficient to inhibit 
apoptosis triggered by oxysterols. Thus, in contrast to gluco-
corticoid induced apoptosis where Bcl-2 possess potent inhib-
itory effects [29,30] evoking in this case a central role of mi-
tochondria [31,32], the anti-apoptotic effects of Bcl-2 on 
oxysterol induced cell death are far less remarkable, indicating 
that oxysterol induced cell death probably involves two path-
ways: Bcl-2 inhibitable and uninhibitable. 
The identification of IL-lß secretion associated with 7ß-hy-
droxycholesterol and 7-ketocholesterol induced apoptosis con-
stitutes the major new finding of this study. IL-lß is synthe-
sized as an inactive 33 kDa propeptide [33] that must be 
processed by proteolytic cleavage in order to be secreted 
[18]. Interestingly, IL-lß secretion has been reported during 
apoptosis [19], and the conversion of pro-IL-lß to IL-lß is 
activated by certain apoptotic signals such as CD95 ligand or 
TNF [13,14,34]. According to these considerations, our data 
lead to suppose that 7ß-hydroxycholesterol and 7-ketocholes-
terol could either activate the conversion of pro-IL-lß to IL-
lß or favor the neosynthesis of this cytokine, and so stimulate 
IL-lß release. As interleukin-lß-converting enzyme was de-
tected in apoptotic cells from advanced human atheroma 
[35], we can suppose, according to our data, that oxysterols 
present at elevated concentrations in human atherosclerotic 
lesions [36] could be involved in vivo in the induction of IL-
lß synthesis by apoptotic cells. Therefore, in certain condi-
tions and mainly in the present study, IL-lß secretion would 
be a product of apoptosis [19], and up to now there is no 
evidence that enhanced IL-lß secretion contributes to apop-
tosis. Indeed, knockout mice which are caspasel deficient and 
therefore do not generate mature IL-lß develop normally and 
the ex vivo response of cells to various apoptotic stimuli is 
indistinguishable from cells derived from wild-type animals 
[12]. In addition, as 7ß-hydroxycholesterol and 7-ketocholes-
terol can stimulate IL-8 production which is chemotactic for T 
lymphocytes and neutrophils at picomolar and nanomolar 
concentrations [37], and as IL-1 can induce both in vitro 
and in vivo endothelial expression of the adhesion molecules 
E-selectin, ICAM-1 and VCAM-1 which are involved in the 
local adhesion and the subendothelial accumulation of T-cells 
and monocytes [38,39], we speculate that these oxysterols 
could play a critical role in the recruitment of immunocom-
petent cells in the atherosclerotic plaque. Interestingly, Bcl-2 
overexpression was associated with a lower IL-lß secretion in 
U4 cells treated with 7ß-hydroxycholesterol than in U4 cells 
treated with 7-ketocholesterol suggesting that the biological 
effects of oxysterols could be structure dependent as previ-
ously supposed by the various potencies of these compounds 
to induce apoptosis [3,5] and to inhibit 3-hydroxy-3-methyl-
glutaryl coenzyme A reducíase activity [40]. 
In conclusion, we confirm that Bcl-2 overexpression parti-
ally antagonize oxysterols induced apoptosis [7], and we 
underline that 7ß-hydroxycholesterol and 7-ketocholesterol 
could constitute major risk factors in atherosclerosis by indue-
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ing simultaneously apoptosis and I L - l ß secretion. Indeed, in 
vivo, 7ß-hydroxycholesterol and 7-ketocholesterol could sim-
ilarly induced apoptosis on the cells of the vascular wall and 
favor I L - l ß release to recruit immunocompetent cells which 
will further contribute to the initiation and to the develop-
ment of the lesion [39]. 
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